Literature DB >> 11388783

Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson's disease?

S Johnson1.   

Abstract

Zinc has several crucial functions in brain development and maintenance: it binds to p53, preventing it from binding to supercoiled DNA and ensuring that p53 cause the expression of several paramount genes, such as the one that encodes for the type I receptors to pituitary adenine cylase-activator peptide (PACAP), which directs embryonic development of the brain cortex, adrenal glands, etc.; it is required for the production of CuZnSOD and Zn-thionein, which are essential to prevent oxidative damage; it is required for many proteins, some of them with Zn fingers, many of them essential enzymes for growth and homeostasis. For example, the synthesis of serotonin involves Zn enzymes and since serotonin is necessary for melatonin synthesis, a Zn deficiency may result in low levels of both hormones. Unfortunately, Zn levels tend to be low when there is excess Cu and Cd. Moreover, high estrogen levels tend to cause increased absorption of Cu and Cd, and smoking and eating food contaminated with Cd result in high levels of the latter. Furthermore, ethanol ingestion increases the elimination of Zn and Mg (which acts as a cofactor for CuZnSOD). Increased Cu levels may also be found in people with Wilson's disease, which is a rather rare disease. However, the heterozygote form (only one faulty copy of the chromosome) is not so rare. Therefore, the developing fetus of a pregnant women who is low in Zn and high in Cu may experience major difficulties in the early development of the brain, which may later manifest themselves as schizophrenia, autism or epilepsy. Similarly, a person who gradually accumulates Cu, will tend to experience a gradual depletion of Zn, with a corresponding increase in oxidative damage, eventually leading to Parkinson's disease. Also discussed are the crucial roles of histidine, histamine, vitamin D, essential fatty acids, vitamin E, peroxynitrate, etc. in the possible oxidative damage involved in these mental diseases. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11388783     DOI: 10.1054/mehy.2000.1302

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  11 in total

1.  Zinc Supplementation and Body Weight: A Systematic Review and Dose-Response Meta-analysis of Randomized Controlled Trials.

Authors:  Shima Abdollahi; Omid Toupchian; Ahmad Jayedi; David Meyre; Vivian Tam; Sepideh Soltani
Journal:  Adv Nutr       Date:  2020-03-01       Impact factor: 8.701

2.  Environmental factors in autism.

Authors:  Andreas M Grabrucker
Journal:  Front Psychiatry       Date:  2013-01-18       Impact factor: 4.157

Review 3.  The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease.

Authors:  Elizabeth A Mazzio; Fran Close; Karam F A Soliman
Journal:  Int J Mol Sci       Date:  2011-01-17       Impact factor: 5.923

4.  Essential trace metals and heavy metals in newly diagnosed schizophrenic patients and those on anti-psychotic medication.

Authors:  Ganiyu Arinola; Blessing Idonije; Kehinde Akinlade; Olubisi Ihenyen
Journal:  J Res Med Sci       Date:  2010-09       Impact factor: 1.852

5.  Status of plasma nitric oxide and non-enzymatic antioxidants before and after antipsychotic treatment in Nigerian patients with schizophrenia.

Authors:  Og Arinola; Ob Idonije
Journal:  J Res Med Sci       Date:  2009-01       Impact factor: 1.852

6.  Clinical features, proximate causes, and consequences of active convulsive epilepsy in Africa.

Authors:  Symon M Kariuki; William Matuja; Albert Akpalu; Angelina Kakooza-Mwesige; Martin Chabi; Ryan G Wagner; Myles Connor; Eddie Chengo; Anthony K Ngugi; Rachael Odhiambo; Christian Bottomley; Steven White; Josemir W Sander; Brian G R Neville; Charles R J C Newton; Rhian Twine; F Xavier Gómez Olivé; Mark Collinson; Kathleen Kahn; Stephen Tollman; Honratio Masanja; Alexander Mathew; George Pariyo; Stefan Peterson; Donald Ndyomughenyi; Evasius Bauni; Gathoni Kamuyu; Victor Mung'ala Odera; James O Mageto; Ken Ae-Ngibise; Bright Akpalu; Francis Agbokey; Patrick Adjei; Seth Owusu-Agyei; Immo Kleinschmidt; Victor C K Doku; Peter Odermatt; Thomas Nutman; Patricia Wilkins; John Noh
Journal:  Epilepsia       Date:  2013-10-07       Impact factor: 5.864

7.  Dietary Patterns of Children with Autism Spectrum Disorder: A Study Based in Egypt.

Authors:  Nagwa Meguid; Mona Anwar; Safaa Zaki; Wafaa Kandeel; Nihad Ahmed; Ihab Tewfik
Journal:  Open Access Maced J Med Sci       Date:  2015-05-07

8.  Leptin and zinc relation: In regulation of food intake and immunity.

Authors:  Abdulkerim Kasim Baltaci; Rasim Mogulkoc
Journal:  Indian J Endocrinol Metab       Date:  2012-12

Review 9.  Nutraceuticals in Parkinson's Disease.

Authors:  Liting Hang; Adeline Henry Basil; Kah-Leong Lim
Journal:  Neuromolecular Med       Date:  2016-05-04       Impact factor: 3.843

10.  Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo-controlled, double-blind trial.

Authors:  Hoda Khorsandi; Omid Nikpayam; Reyhaneh Yousefi; Maryam Parandoosh; Nima Hosseinzadeh; Atoosa Saidpour; Arman Ghorbani
Journal:  Diabetol Metab Syndr       Date:  2019-12-02       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.